956 related articles for article (PubMed ID: 32687917)
41. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.
Amawi H; Abu Deiab GI; A Aljabali AA; Dua K; Tambuwala MM
Ther Deliv; 2020 Apr; 11(4):245-268. PubMed ID: 32397911
[TBL] [Abstract][Full Text] [Related]
42. [COVID-19: Pathogenesis of a multi-faceted disease].
Bonny V; Maillard A; Mousseaux C; Plaçais L; Richier Q
Rev Med Interne; 2020 Jun; 41(6):375-389. PubMed ID: 32507520
[TBL] [Abstract][Full Text] [Related]
43. Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
Gyanwali P; Sharma S; Pant S; Koirala P; Adhikari K; Koirala J; Dhimal M
J Nepal Health Res Counc; 2020 Sep; 18(2):151-158. PubMed ID: 32969369
[TBL] [Abstract][Full Text] [Related]
44. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.
Subbarao K; Mordant F; Rudraraju R
Eur J Immunol; 2020 Oct; 50(10):1447-1453. PubMed ID: 32886952
[TBL] [Abstract][Full Text] [Related]
45. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies.
Dhama K; Patel SK; Pathak M; Yatoo MI; Tiwari R; Malik YS; Singh R; Sah R; Rabaan AA; Bonilla-Aldana DK; Rodriguez-Morales AJ
Travel Med Infect Dis; 2020; 37():101755. PubMed ID: 32479816
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
Yeleswaram S; Smith P; Burn T; Covington M; Juvekar A; Li Y; Squier P; Langmuir P
Clin Immunol; 2020 Sep; 218():108517. PubMed ID: 32585295
[TBL] [Abstract][Full Text] [Related]
47. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
[TBL] [Abstract][Full Text] [Related]
48. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
49. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
50. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
Kumar V
Int Immunopharmacol; 2020 Nov; 88():106980. PubMed ID: 33182073
[TBL] [Abstract][Full Text] [Related]
51. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
52. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
[TBL] [Abstract][Full Text] [Related]
53. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
El-Missiry MA; El-Missiry ZMA; Othman AI
Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiology and treatment strategies for COVID-19.
Kumar M; Al Khodor S
J Transl Med; 2020 Sep; 18(1):353. PubMed ID: 32933536
[TBL] [Abstract][Full Text] [Related]
55. COVID-19: immunopathogenesis and Immunotherapeutics.
Yang L; Liu S; Liu J; Zhang Z; Wan X; Huang B; Chen Y; Zhang Y
Signal Transduct Target Ther; 2020 Jul; 5(1):128. PubMed ID: 32712629
[TBL] [Abstract][Full Text] [Related]
56. Update on neurological manifestations of COVID-19.
Yavarpour-Bali H; Ghasemi-Kasman M
Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
[TBL] [Abstract][Full Text] [Related]
57. A hypothesis on the role of the human immune system in covid-19.
Khashkhosha HK; Elhadi M
Med Hypotheses; 2020 Oct; 143():110066. PubMed ID: 32629204
[TBL] [Abstract][Full Text] [Related]
58. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
59. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
60. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
